Generic Name: alitretinoin topical (ah lih TREH tin oyn)
Brand Name: Panretin
What is alitretinoin topical?
Alitretinoin is a retinoid, related to vitamin A. Alitretinoin affects the growth and development of skin cells.
Alitretinoin topical (for the skin) is used to treat skin lesions caused by AIDS-related Kaposi's sarcoma.
Alitretinoin topical may also be used for purposes not listed in this medication guide.
What is the most important information I should know about alitretinoin topical?
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
What should I discuss with my healthcare provider before using alitretinoin topical?
You should not use this medicine if you are allergic to alitretinoin, isotretinoin, or tretinoin (Retin-A).
Before you use alitretinoin topical, tell your doctor about all your medical conditions and allergies. Also make sure your doctor knows if you are pregnant or breast-feeding.
FDA pregnancy category D. Do not use alitretinoin topical if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment.
It is not known whether alitretinoin topical passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using this medicine.
Do not use this medication on anyone under 18 years old without medical advice.
How should I use alitretinoin topical?
Follow all directions on your prescription label. Do not use this medicine in larger or smaller amounts or for longer than recommended.
Wash your hands before and after using this medicine, unless you are treating skin areas on your hands.
Apply this medication only to affected skin lesions. Try not to get any medicine on the healthy skin around the lesions.
Allow the gel to dry for 3 to 5 minutes before covering treated skin with clothing. Do not bathe, shower, or swim for at least 3 hours after applying the medicine.
Do not cover the treated skin area with a bandage or similar covering unless your doctor tells you to.
It may take up to 14 weeks or longer before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve.
Do not share this medication with another person, even if they have the same symptoms you have.
Store at room temperature away from moisture and heat. Keep the medicine away from open flame or high heat.
What happens if I miss a dose?
Apply the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.
What happens if I overdose?
An overdose of alitretinoin topical is not expected to be dangerous. Seek emergency medical attention or call the Poison Help line at 1-800-222-1222 if anyone has accidentally swallowed the medication.
What should I avoid while using alitretinoin topical?
Avoid getting this medication in your eyes, nose, mouth, rectum, or vagina. If this does happen, rinse with water.
Do not use insect repellents or other products that contain DEET (N,N-diethyl-m-toluamide) while using alitretinoin topical.
Avoid exposure to sunlight or tanning beds while using this medicine. Alitretinoin can make you sunburn more easily. Wear protective clothing when you are outdoors.
Alitretinoin topical side effects
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using this medicine and call your doctor at once if you have:
severe redness or swelling of treated skin areas;
peeling or scaly skin;
scabbing or crusting; or
blistering or oozing of treated skin.
Common side effects may include:
numbness or tingling;
dryness or cracking of the skin; or
mild itching, burning, or other skin irritation.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)
Alitretinoin topical dosing information
Usual Adult Dose for Kaposi's Sarcoma:
For use in the topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma: Initially, a generous amount of alitretinoin topical gel should be applied to each lesion twice a day.
The application frequency may be gradually increased to 3 or 4 times a day according to individual lesion tolerance. If application site toxicity occurs, the application frequency may be reduced. If irritation is severe, application of the drug may be discontinued for a few days until symptoms subside.
Response of Kaposi's sarcoma lesions may be seen as early as 2 weeks after initiating therapy; however, most patients require longer treatment. Some patients required over 14 weeks to respond to therapy. In clinical trials, alitretinoin topical was applied for up to 96 weeks. The manufacturer recommends continuing therapy as long as the patient is deriving benefit.
What other drugs will affect alitretinoin topical?
It is not likely that other drugs you take orally or inject will have an effect on topically applied alitretinoin. But many drugs can interact with each other. Tell each of your health care providers about all medicines you use, including prescription and over-the-counter medicines, vitamins, and herbal products.
More about alitretinoin topical
- Other brands: Panretin
Related treatment guides
Where can I get more information?
- Your pharmacist can provide more information about alitretinoin topical.
- Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
- Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2012 Cerner Multum, Inc. Version: 3.01. Revision Date: 2013-09-25, 11:39:03 AM.